129 related articles for article (PubMed ID: 37381013)
1. Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models.
Yin X; Li Y; Bagchus W; Yalkinoglu Ö; Bezuidenhout D; Tappert A; McCarthy J; Marquart L; Oeuvray C
Malar J; 2023 Jun; 22(1):199. PubMed ID: 37381013
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
[TBL] [Abstract][Full Text] [Related]
4. The delayed bloodstream clearance of
Parkyn Schneider M; Looker O; Rebelo M; Khoury DS; Dixon MWA; Oeuvray C; Crabb BS; McCarthy J; Gilson PR
Front Cell Infect Microbiol; 2023; 13():1211613. PubMed ID: 37457953
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
6. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
Flegg JA; Guerin PJ; White NJ; Stepniewska K
Malar J; 2011 Nov; 10():339. PubMed ID: 22074219
[TBL] [Abstract][Full Text] [Related]
7. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies.
Woolley SD; Fernandez M; Rebelo M; Llewellyn SA; Marquart L; Amante FH; Jennings HE; Webster R; Trenholme K; Chalon S; Moehrle JJ; McCarthy JS; Barber BE
Malar J; 2021 Feb; 20(1):93. PubMed ID: 33593375
[TBL] [Abstract][Full Text] [Related]
9. Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model.
Sharifi-Malvajerdi S; Zhu F; Fogarty CB; Fay MP; Fairhurst RM; Flegg JA; Stepniewska K; Small DS
Malar J; 2019 Jan; 18(1):4. PubMed ID: 30611278
[TBL] [Abstract][Full Text] [Related]
10. Parasite-Host Dynamics throughout Antimalarial Drug Development Stages Complicate the Translation of Parasite Clearance.
Burgert L; Zaloumis S; Dini S; Marquart L; Cao P; Cherkaoui M; Gobeau N; McCarthy J; Simpson JA; Möhrle JJ; Penny MA
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526486
[TBL] [Abstract][Full Text] [Related]
11. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
[TBL] [Abstract][Full Text] [Related]
12. Quantification of parasite clearance in Plasmodium knowlesi infections.
T Thurai Rathnam J; Grigg MJ; Dini S; William T; Sakam SS; Cooper DJ; Rajahram GS; Barber BE; Anstey NM; Haghiri A; Rajasekhar M; Simpson JA
Malar J; 2023 Feb; 22(1):54. PubMed ID: 36782162
[TBL] [Abstract][Full Text] [Related]
13. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.
Flegg JA; Guérin PJ; Nosten F; Ashley EA; Phyo AP; Dondorp AM; Fairhurst RM; Socheat D; Borrmann S; Björkman A; Mårtensson A; Mayxay M; Newton PN; Bethell D; Se Y; Noedl H; Diakite M; Djimde AA; Hien TT; White NJ; Stepniewska K
Malar J; 2013 Nov; 12():411. PubMed ID: 24225303
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
Rottmann M; Jonat B; Gumpp C; Dhingra SK; Giddins MJ; Yin X; Badolo L; Greco B; Fidock DA; Oeuvray C; Spangenberg T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041711
[TBL] [Abstract][Full Text] [Related]
15. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
16. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
Fukuda N; Balikagala B; Ueno T; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Miida T; Mita T
Clin Infect Dis; 2023 May; 76(9):1585-1593. PubMed ID: 36519341
[TBL] [Abstract][Full Text] [Related]
18. Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites.
Diakite M; Achidi EA; Achonduh O; Craik R; Djimde AA; Evehe MS; Green A; Hubbart C; Ibrahim M; Jeffreys A; Khan BK; Kimani F; Kwiatkowski DP; Mbacham WF; Jezan SO; Ouedraogo JB; Rockett K; Rowlands K; Tagelsir N; Tekete MM; Zongo I; Ranford-Cartwright LC
Malar J; 2011 Aug; 10():250. PubMed ID: 21867552
[TBL] [Abstract][Full Text] [Related]
19. Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis.
WorldWide Antimalarial Resistance Network White Blood Cell Count in Malaria Study Group
Malar J; 2023 Jun; 22(1):174. PubMed ID: 37280686
[TBL] [Abstract][Full Text] [Related]
20. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
